Alife  

San Francisco,  CA 
United States
https://www.alifehealth.com/

• Booth: 840

Alife is a technology company using artificial intelligence to improve IVF outcomes and streamline clinic operations. Powered by one of the largest IVF datasets in the world, Alife’s products deliver data-driven insights to assist clinical decision making at every step of the IVF process. The platform is a multi-product solution for reproductive endocrinology, embryology, and clinic management to help optimize treatment outcomes, streamline workflows, and track performance in real time.

 Videos

 Press Releases

• Alife Launches New AI Platform to Optimize IVF (Sep 08, 2023)

  SAN FRANCISCO, October 24, 2022 – Alife Health announced the launch of its Alife Assist™ platform today. This new suite of products aims to help fertility clinics utilize and leverage data-driven insights and artificial intelligence (AI) to optimize and support clinical decision-making during critical stages of the in-vitro fertilization (IVF) process, as well as streamline overall clinic operations. This marks the company’s official entry into the clinical market after conducting two years of research and development with its notable list of clinic partners, advisors, and investors.

   

  “I founded Alife because I knew that AI has the potential to drastically impact the IVF process. Yet, as we began to work with fertility clinics around the country, we quickly identified a parallel opportunity for improvement: the need for a central platform to digitize clinic workflow and support collective decision-making. Our team is thrilled to launch Alife Assist™, a first-of-its-kind product suite that optimizes the IVF process from end-to-end,” says Paxton Maeder-York, CEO of Alife. “Together, our products will help clinics harness the power of AI and advanced analytics to streamline their workflow and bring a more personalized experience to their patients.”

   

  “AI has enormous potential to help inform our decisions as clinicians. When it comes to patient care decision making, the more data and information, the better. If we can harness the knowledge of thousands of past patient cycles from clinics around the world, we can make more informed choices about the patient sitting right in front of us,” says Louis Weckstein, MD.

   

  The Alife Assist™platform is made up of three robust products that are supported by the team’s scientific research and collaboration with top clinics:

   

  • Stim Assist™ is a set of AI-powered clinical decision support tools that helps reproductive endocrinologists choose the optimal medication dose and timing to maximize the number of mature eggs retrieved from an ovarian stimulation cycle. These tools use one of the largest and most diverse IVF datasets in the world which contains millions of rows of historical data from previous patient cycles to provide insights on what treatment has worked best for similar patients. Alife's research indicates that in general more mature oocytes are associated with a higher live birth percentage.

   

  • Embryo Assist™ streamlines and enhances an embryologist's workflow in a single tool to keep consistent records, save time, and automate reports. This enables embryologists to digitally capture, grade, organize, and report embryo grading data like never before, all with real-time EMR connection. 

   

  • Insights™ is an analytics dashboard that gives directors, managers, and administrators the ability to monitor and visualize their clinic’s performance in real-time. This simplifies the process of extracting trends and sharing reports to optimize overall clinic operations. 

   

  Alife Assist™ is now available for IVF clinics in the United States. For those interested in exploring Alife Assist™ further, email clinics@alifehealth.com to learn more or schedule a product demo at alifehealth.com/request-a-demo.

   

  ABOUT ALIFE HEALTH

  Alife’s mission is to modernize and personalize the IVF process with cutting edge artificial intelligence technology to improve outcomes and care for all. The company has built a consortium of partnerships with the top clinics and most renowned physicians to bring significant clinical improvements to patients globally. Founded by Paxton Maeder-York in 2020, the company is based in San Francisco and backed by top tier venture capital investors including Lux Capital, Union Square Ventures, and Maveron. To learn more visit www.alifehealth.com.

   

  PRESS CONTACT

  Jamie Gray, press@alifehealth.com 

• Innovation Fertility Partners with Alife Health to Bring AI to IVF Clinics Around the Country (Sep 08, 2023)

  SAN FRANCISCO, MARCH 16, 2023 – Innovation Fertility, a group of in-vitro fertilization (IVF) clinics and laboratories, and Alife Health, a fertility technology company, today announced their partnership to introduce new artificial intelligence (AI) and advanced analytics technology to the Innovation Fertility network. This collaboration will provide Innovation Fertility clinics with the latest in AI-powered analytics tools so they can make the most informed decisions about patient care.

   

  Innovation Fertility is led by an expert team of fertility professionals that boast decades of experience in laboratory design, advanced technology implementation, and strategic planning to build successful fertility practices.

   

  “Our leadership team has always been driven to discover the most cutting-edge, science-backed technologies in our field,” says Dr. Kathleen Miller, Chief Science Officer at Innovation Fertility. “If we want to provide the best possible care to our patients, we know we need to leverage the potential that modern technology offers. Alife has worked hand-in-hand with us to build products that will not only help our clinics work more efficiently and effectively, but will also help us to build more personalized treatment plans for our patients.” 

   

  Alife Health was founded in 2020 by a team of data scientists, product engineers, and software designers to build a modern operating system for IVF, powered by artificial intelligence. After two years of scientific research and product development, the company officially launched their first product, Alife Assist™, last fall at the American Society for Reproductive Medicine (ASRM) Scientific Congress & Expo. A first-of-its-kind software platform, Alife Assist™ utilizes data-driven insights and AI to optimize and support clinical decision-making during critical stages of the IVF process, as well as streamline overall clinic operations. 

   

  “We’re thrilled to be working with Innovation Fertility to introduce new technologies that will push the field forward and help clinics in their effort to give more patients successful outcomes,” says Alife CEO and Founder, Paxton Maeder-York. “Alife's AI and advanced analytics technology provides IVF clinicians with personalized patient insights and predictions drawn from thousands of previous patient cycles from across the country. With this information, clinicians can craft individualized data-driven treatment recommendations to provide their patients optimal care and increase their chances of having a baby.”

   

  This partnership is yet another example of how innovation is transforming the field of assisted reproduction - making it easier for couples struggling with infertility to achieve their dreams of becoming parents.

   

  About Alife Health

  Alife’s mission is to personalize and modernize the IVF process with cutting edge artificial intelligence technology to improve outcomes and care for all. The company has built a consortium of partnerships with the top clinics and most renowned physicians to bring significant clinical improvements to patients globally. Founded by Paxton Maeder-York in 2020, the company is based in San Francisco and backed by top tier venture capital investors including Lux Capital, Union Square Ventures, and Maveron. To learn more visit www.alifehealth.com.

   

  About Innovation Fertility

  Innovation Fertility provides patients with innovative, cutting-edge fertility treatment options to meet their unique family planning goals. As a team, they combine premier reproductive endocrinologists with laboratory operations, resulting in exceptional medical care and an unparalleled patient experience. To learn more visit https://www.iffertility.com/. 

   

  Contact Info

  Alife Health: Jamie Gray, press@alifehealth.com, 310-699-3163

• Alife Health Launches Mobile App to Help Patients Navigate Their IVF Journey (Sep 08, 2023)

  SAN FRANCISCO, May 15, 2023 – Alife Health, a technology company building AI tools to advance fertility care, announced today the launch of its mobile application to help patients navigate their IVF journey from beginning to end. The Alife app is free for all iPhone users, offering easy-to-use test result tracking, medication and appointment reminders, educational information, and a timeline to prepare for next steps. 

   

  There are many challenges that patients face when being treated for infertility. On top of an already physically and emotionally onerous process, IVF patients carry the mental burden of managing their medications, appointments, insurance claims, and more. 

   

  "Beyond just creating AI software to enhance IVF outcomes on the clinical side, our team recognized the need to provide patients with better tools as well,” says Paxton Maeder-York, CEO of Alife. “We understand the stress that comes with managing the IVF process, from keeping track of loose paperwork to countless medication alarms. To alleviate this burden, we developed the Alife app - a comprehensive tool that enables patients to easily manage their IVF journey straight from their phones. By consolidating everything they need in one place, the Alife app empowers patients to stay informed and feel in control, which we hope will ultimately lead to a more positive and stress-free experience."

   

  Key features of the Alife app include:

  • Track your journey
    • Set reminders for appointments, medications and to-dos
    • Record results, symptoms, notes and costs
    • Compare cycles, past and present
  • Prepare for what’s next
    • See what’s upcoming with your personalized journey timeline
    • Learn what to expect at each step of the process
    • Read educational blog articles to keep you informed
  • Customize your timeline
    • Add procedures as you go
    • Remove optional steps from your timeline
    • Input past procedures to accurately reflect your journey, past and present

   

  “After going through IVF multiple times myself, I can tell you that the time commitment needed to manage this process can be the equivalent of a part time job,” says Halle Tecco, women's health leader and Alife advisor. “The Alife app is the first resource for IVF patients that is truly built around the patient experience and fills gaps in the process. From pure organization to empowering patients with education on each step, the Alife app is a one-stop-shop for simplifying IVF management.”

   

  The Alife app is currently available on iOS in the U.S. and Canada. The app can be downloaded here. Please click here for high-res imagery. 

   

  ABOUT ALIFE HEALTH

  Alife’s mission is to modernize and personalize the IVF process with cutting edge artificial intelligence technology to improve outcomes and care for all. The company has built a consortium of partnerships with the top clinics and most renowned physicians to bring significant clinical improvements to patients globally. Founded by Paxton Maeder-York in 2020, the company is based in San Francisco and backed by top tier venture capital investors including Lux Capital, Union Square Ventures, and Maveron. To learn more visit www.alifehealth.com.

   

  PRESS CONTACT

  Jamie Gray, press@alifehealth.com 

 Products